Adam J. Waxman, MD
Assistant Professor of Clinical Medicine (Hematology-Oncology)
Attending , Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
12 South Pavilion
Room #12-174
Philadelphia, PA 19104
3400 Civic Center Blvd
12 South Pavilion
Room #12-174
Philadelphia, PA 19104
Publications
Education:
BA (Chemistry)
New York University, 2007.
MD (Medicine)
Duke University School of Medicine, 2011.
Permanent linkBA (Chemistry)
New York University, 2007.
MD (Medicine)
Duke University School of Medicine, 2011.
Description of Clinical Expertise
Multiple MyelomaAmyloidosis
Monoclonal Gammopathies
Paraprotein Mediated Renal Disease
Cryoglobulinemia
Autologous Stem Cell Transplantation
Chronic Lymphocytic Leukemia
Indolent Lymphomas
Description of Research Expertise
Multiple Myeloma and Amyloidosis Clinical TrialsSelected Publications
Yu KL, Ho M, Paruzzo L, Stella F, Patel H, Hasanali ZS, Kapur S, Waxman AJ, Vogl DT, Stadtmauer EA, Fraietta JA, Ruella M, Cohen AD, Garfall AL, Susanibar-Adaniya S.: Outcomes of relapse after teclistamab therapy in multiple myeloma. Blood Cancer Journal 15(1): 193, November 2025.Kyle L. Yu, Matthew Ho, Luca Paruzzo, Federico Stella, Heta Patel, Zainul S. Hasanali, Shivani Kapur, Adam J. Waxman, Dan T. Vogl, Edward A. Stadtmauer, Joseph A. Fraietta, Marco Ruella, Adam D. Cohen, Alfred L. Garfall & Sandra Susanibar-Adaniya: Outcomes of relapse after teclistamab therapy in multiple myeloma. Blood cancer journal 15(1), Nov 2025.
Ho M, Paruzzo L, Minehart J, Voruganti T, Devi P, Vogl DT, Cohen AD, Garfall AL, Waxman AJ, Kapur S, Stadtmauer EA, Adaniya SS, Longworth S.: Non-tuberculous mycobacterial infections following teclistamab in multiple myeloma. Haematologica 110(6), June 2025.
Stalker M, Garfall A, Cohen A, Vogl DT, Djulbegovic M, Susanibar-Adaniya S, Stadtmauer E, Megherea O, Waxman AJ.: Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis. European Journal of Haematology 114(3), March 2025.
Elghawy O, Deshpande S, Sussman J, Garfall A, Cohen A, Kapur S, Susanibar-Adaniya S, Vogl D, Waxman A, Stadtmauer E.: Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma. Bone Marrow Transplant 60(1): 64-68, January 2025.
Stalker M, Garfall A, Cohen A, Vogl DT, Djulbegovic M, Susanibar-Adaniya S, Stadtmauer E, Megherea O, Waxman AJ: Safety and Efficacy of teclistamab in Patients with Relapsed or Refractory AL Amyloidosis. European Journal of Haematology Nov 2024 Notes: doi: 10.1111/ejh.14348. Online ahead of print.
Elghawy O, Deshpande S, Sussman J, Garfall A, Cohen A, Kapur S, Susanibar-Adaniya S, Vogl D, Waxman A, Stadtmauer E.: Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma. Bone Marrow Transplant Oct 2024 Notes: doi: 10.1038/s41409-024-02455-4. Online ahead of print.
Hasanali ZS, Garfall AL, Burzenski L, Shultz LD, Tang Y, Kadu S, Sheppard NC, Liu W, Dopkin D, Vogl DT, Cohen AD, Waxman AJ, Susanibar-Adaniya SP, Carroll M, Stadtmauer EA, Allman D.: Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice. JCI Insight 9(10): e177300. doi: 10.1172/jci.insight.177300. May 2024.
Ghilardi G, Fraietta JA, Gerson JN, Van Deerlin VM, Morrissette JJD, Caponetti GC, Paruzzo L, Harris JC, Chong EA, Susanibar Adaniya SP, Svoboda J, Nasta SD, Ugwuanyi OH, Landsburg DJ, Fardella E, Waxman AJ, Chong ER, Patel V, Pajarillo R, Kulikovskaya I, Lieberman DB, Cohen AD, Levine BL, Stadtmauer EA, Frey NV, Vogl DT, Hexner EO, Barta SK, Porter DL, Garfall AL, Schuster SJ, June CH, Ruella M.: T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nature Medicine 30(4): 984-989, April 2024.
Margaret Stalker MD, Alfred L. Garfall MD MTR, Adam D. Cohen, Dan T. Vogl MD MSCE, Sandra Susanibar-Adaniya MD, Mia Djulbegovic MDMS, Edward A. Stadtmauer MD, Oxana Megherea PharmD, Adam Waxman MD: Safety and Efficacy of Teclistamab in Patients with Relapsed or Refractory AL Amyloidosis: A Retrospective Case Series. American Society of Hematology Annual Meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"